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Abstract
Introduction: The duration of red blood cell (RBC) storage before transfusion may alter RBC function and
supernatant and, therefore, influence the incidence of complications or even mortality.
Methods: A MEDLINE search from 1983 to December 2012 was performed to identify studies reporting age of
transfused RBCs and mortality or morbidity in adult patients.
Results: Fifty-five studies were identified; most were single-center (93%) and retrospective (64%), with only a few, small
randomized studies (eight studies, 14.5%). The numbers of subjects included ranged from eight to 364,037. Morbidity
outcomes included hospital and intensive care unit (ICU) length of stay (LOS), infections, multiple organ failure,
microcirculatory alterations, cancer recurrence, thrombosis, bleeding, vasospasm after subarachnoid hemorrhage, and
cognitive dysfunction. Overall, half of the studies showed no deleterious effects of aged compared to fresh blood on
any endpoint. Eleven of twenty-two (50%) studies reported no increased mortality, three of nine (33%) showed no
increased LOS with older RBCs and eight of twelve (66%) studies showed no increased risks of organ failure. Ten of
eighteen (55%) studies showed increased infections with transfusion of older RBCs. The considerable heterogeneity
among studies and numerous methodological flaws precluded a formal meta-analysis.
Conclusions: In this systematic review, we could find no definitive argument to support the superiority of fresh
over older RBCs for transfusion.
Introduction
Red blood cell (RBC) transfusions are one of the most
common medical interventions [1]. Although they can
be lifesaving, RBC transfusions have come under intense
scrutiny over the last few decades [2]. In a recent review
of 45 observational studies that had reported the impact
of transfusion on outcomes in different patient groups
(trauma; general, cardiac, orthopedic and neurosurgical;
acute coronary syndrome; intensive care (ICU) patients),
RBC transfusion was an independent predictor of death,
infectious complications and acute respiratory distress
syndrome (ARDS) [3].
The ‘storage lesion’ refers to the multiple complex bio-
chemical and biomechanical alterations that occur during
ex vivo storage, modifying RBC properties and the
supernatant [4] (Table 1). A progressive decrease in 2,3-
diphosphoglycerate (DPG) levels may impair oxygen deliv-
ery [5], and a decreased adenosine triphosphate (ATP)
pool reduces Na+-K+-ATPase activity and, possibly, ATP-
mediated hypoxic vasodilation. Decreased antioxidant
capacities of the erythrocyte may alter reduction of methe-
moglobin [6], generating reactive oxygen species (ROS)
through the Fenton reaction. Complex, irreversible mem-
brane changes (including alterations in protein band 3 [7]
and release of procoagulant [8] vesicles) lead to poorly
deformable sphero-echinocytes with increased adherence
to the endothelium [9] and increased susceptibility to pha-
gocytosis [10]. Changes also occur in the supernatant, with
a progressive decrease in pH, increased potassium concen-
tration, and release of proinflammatory molecules, com-
plement or biologically active lipids (platelet-activating
factor). Release of hemoglobin (free or contained in micro-
particles) may scavenge nitric oxide (NO) in the transfu-
sion recipient and lead to vasoconstriction [11] and iron
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and heme may generate redox injuries, cytotoxicity and
inflammation [12,13]. RBCs prone to increased oxidative
injury undergo protein and lipid peroxidation with release
of lysophospholipids, which may cause transfusion-asso-
ciated acute lung injury (ALI) [14]. However, animal mod-
els describing altered blood flow following transfusion of
old RBCs [15,16] may be of limited relevance to humans
[17]. Some alterations described ex vivo, such as the
decreases in 2,3-DPG or ATP levels, may be at least partly
reversible after transfusion [17]. Therefore, the impact of
storage lesions observed in vitro may not be relevant clini-
cally [18,19]. Some recent meta-analyses [20-22] have
been attempted, but the heterogeneity and methodological
limitations of the studies included prevented definitive
conclusions. The duration of RBC storage varies among
units. Large observational studies have reported a mean
duration of RBC storage of between 16 and 21 days [23],
with a maximum storage duration before transfusion
being generally limited to 42 days (with standard preserva-
tive solutions). However, the regulatory requirements for
this limit are based only on the percentage RBC survival
24 h after transfusion (which has to be ≥ 75%), not on oxy-
gen delivery capacities or clinical endpoints [24].
The aim of this article was to review the clinical evi-
dence related to the potential impact of RBC storage on
outcomes in adult patients.
Materials and methods
A MEDLINE search (accessed through Pubmed and Ovid)
of the literature was performed to identify studies in adult
patients that linked the duration of storage of transfused
RBCs with physiologic variables (oxygen consumption,
alterations of microcirculation), morbidity and mortality.
Morbidity outcomes included infection; postoperative
bleeding; thrombosis, including myocardial infarction;
duration of mechanical ventilation; multiple organ dysfunc-
tion including acute renal failure; ICU and hospital lengths
of stay (LOS); and other less common endpoints, such
as cancer recurrence, vasospasm after subarachnoid hemor-
rhage (SAH) or cognitive dysfunction. Medical Subject
Headings (MeSH) terms (‘Erythrocytes’, ‘Blood Transfu-
sion’, ‘Mortality’, ‘Infection’, ‘Pneumonia’, ‘Acute Kidney
Injury’, ‘Length of Stay’, ‘Multiple Organ Failure’,
‘Respiration, Artificial’, ‘Venous Thrombosis’, ‘Neoplasms’,
‘Microcirculation’, ‘Oxygen Consumption’, ‘Vasospasm,
Intracranial’) and non-MeSH terms (’Age’, ‘Storage’, ‘Dura-
tion’) were used for the search process. All studies on adult
patients (more than 19 years old) published from 1983 to
December 2012 (last access, December 15, 2012) and writ-
ten in any language were selected for individual screening.
The Cochrane Library was searched using the same search
strategy. Bibliographic references of relevant studies were
also checked manually to complete the search process.
Review articles, editorials, meta-analyses, abstracts of scien-
tific meetings or studies that were subsequently retracted
were not included. The flow diagram related to the search
process is shown in Figure 1 according to the PRISMA
statement [25]. Once selected, additional data regarding
potential confounders (for example, data on leukoreduction
status) were collected, and studies were grouped according
to their primary outcome measure for qualitative synthesis.
Given their particular importance in causal inference,
Table 1 Main components of the storage lesion.
Changes occurring to the RBC Changes occurring in the supernatant
Metabolic changes
• Decreased 2-3 DPG, possibly with impaired oxygen delivery [5]
• Decreased phosphate and adenine pool (AMP, ADP, ATP) [24]
• Decreased glutathione levels [6]
• Decreased S-nitroso hemoglobin [110]
• Increased lactate levels
• Decreased pH
• Increased potassium concentrations (decreased Na-K-ATPase activity)
with increased risks of hyperkalemia
• Release of various molecules:
○ Proinflammatory cytokines (IL-1beta, IL-6, IL-8, TNF-alpha) and
complement
○ Biologically active lipids such as platelet-activating factor (PAF) [14]
○ Free hemoglobin prone to scavenge nitric oxide (NO) of the
recipient (together with Hb-containing microparticles) [109]
○ Heme and iron [12] with potential redox injuries, cytotoxicity and
inflammation
Oxidative stress
• Protein oxidation including cytoskeleton [111]
• Lipid peroxidation, generation of lysophospholipids prone to cause cases of
TRALI, generation of prostaglandins and isoprostanes [112]
Shape and membrane changes
• Shift from early reversible echinocytes to irreversible sphero-echinocytes
• Generation of microvesicles with procoagulant properties
• Increased RBC rigidity and adherence to vascular endothelium2
• Decreased CD47 expression, increased phosphatidylserine exposure
ADP, adenosine diphosphate; AMP, adenosine monophosphate; ATP, adenosine triphosphate; DPG, diphosphoglycerate; Hb, hemoglobin; IL, interleukin; RBC, red
blood cell; TNF-alpha, tumor necrosis factor alpha; TRALI, transfusion-related acute lung injury.
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randomized controlled trials (RCTs) were also considered
separately.
Mean values are given +/- standard deviation (SD) and
median values are given with interquartile ranges (IQR).
All relative risks (RR), odds ratios (OR) or hazard ratios
(HR) are provided with 95% confidence intervals (CI).
Results
The search process retrieved 4,053 (3,902 after duplicate
removal) studies, of which 2,183 were excluded, leaving
1,719 studies that were assessed for eligibility (Figure 1).
Of these, 1,664 were excluded for various reasons
(reviews and editorials, meta-analyses, subsequent
Figure 1 Flow diagram of study selection.
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retraction of one study on cardiac surgery patients
[26,27], and studies not reporting RBC storage variables
or no clinical endpoint as defined earlier). Accordingly,
the analysis included 55 studies (Table 2), with a total of
407,185 patients. Most studies were retrospective (n =
35, 64%) and single-center (n = 51, 93%). The number
of transfused subjects ranged from eight to 364,037
(median: 268 patients, IQR: 61 to 757). Only a small
proportion of the studies were randomized trials (n = 8,
14.5%); the eight randomized studies had fewer included
patients (median = 21 patients, IQR: 10.5 to 83.75) and,
in the majority, physiological variables were reported as
the primary outcome measure (n = 6 studies) (Table 3).
Effect on mortality
We identified 22 studies that reported mortality as an
endpoint, 20 of which were retrospective. Six studies
focused on trauma patients, five on cardiac surgery
patients, four on ICU patients and seven on mixed or
other populations (patients with colorectal cancer,
patients with cardiovascular disease or undergoing percu-
taneous coronary intervention, patients receiving hema-
topoietic stem cell transplantation or undergoing liver
transplantation). Among these 22 studies, only one was a
randomized trial, but this single-center study was small
and not primarily powered for mortality [28]. In this trial
conducted on 100 mechanically ventilated ICU patients,
patients randomized to exclusively receive fresh RBCs
(n = 50, median RBC age: 4.0 days) had similar mortality
rates (36% in the fresh group vs. 40% in the standard
issue group, P = 0.41) than those receiving standard
RBCs (n = 50, median RBC age: 26.5 days) [28]. We iden-
tified one prospective, observational study, an Australian
multicenter study of 757 critically ill patients (including a
mix of medical and surgical patients) in which exposure
to the highest age quartile of RBCs (average age: 17.6
days) was associated with a significantly higher hospital
mortality rate compared to lowest quartile (average age:
7.5 days) RBCs, even after correction for disease severity
(APACHE III score) and the number of units transfused
(OR: 2.01 (1.07 to 3.77), P = 0.03) [29].
The largest study to date exploring the association
between age of transfused RBCs and mortality comes
from the Swedish/Danish SCANDAT database exploring
404,959 transfusion episodes in more than 300,000
(mainly trauma and surgical) patients from 1995 to 2002:
administration of RBCs aged 30 to 42 days was associated
with a 5% increased mortality (HR: 1.05; 95% CI, 1.02 to
1.08) after two years of follow-up [30], but the authors
acknowledged that this risk could have been overesti-
mated in view of a greater baseline risk in recipients of
older units. In another retrospective, registry-based ana-
lysis of 6,994 surgical patients with comorbidities (ASA
score more than III in 80% of patients; cardiac surgery
patients excluded) receiving a median of two leukore-
duced RBC units, Saager et al. found no relationship
between median RBC storage duration and postoperative
mortality (up to two years) in a Cox regression model
(adjusting for ABO group and number of units trans-
fused) [31].
Some studies included more homogeneous patient
populations. In cardiac surgery patients, the largest study
was a single-center, retrospective study of 6,002 patients
undergoing coronary artery bypass graft (CABG), valve
surgery or both. Patients transfused with older blood
(median: 20 days) had greater hospital mortality compared
to those receiving fresher (median: 11 days) blood (2.8%
vs. 1.7%, P = 0.004). Patients transfused with older blood
also had a higher one-year mortality rate (11.0 vs. 7.4%,
P < 0.001) [32]. However, these results were much debated
and challenged by other groups that were unable to find
such an association [33-37]. In a single-center study of
2,732 patients undergoing CABG, van de Watering et al.
[38] found no correlation between storage time variables
and 30-day mortality in adjusted multivariate analyses. In
this study, 30-day mortality was similar in patients receiv-
ing exclusively older (mean: 24.3 +/- 3.5 days) or younger
RBCs (mean: 12.7 +/- 2.8 days). In a retrospective study of
1,153 cardiac surgery patients, McKenny et al. [39] found
no association between RBC storage duration and post-
operative mortality in a multivariate analysis. In another
retrospective, single-center study of 3,597 patients with
isolated CABG, van Straten et al. [40] found no effect of
RBC storage duration on early or late postoperative mor-
tality. In a single-center, retrospective cohort study of 670
patients undergoing CABG and/or valve surgery, Yap and
coworkers also found no association between storage
duration and mortality [41].
Two retrospective studies examined the association of
RBC storage with mortality in critically ill patients. The
first was a small cohort of 31 septic patients in which
non-survivors received a greater proportion of older
RBCs (> 20 days old) compared to survivors, who
received a greater proportion of younger RBCs (< 10
days old) [42]. In another retrospective, single-center
study of 534 general ICU patients, there was no associa-
tion between the age of transfused red cells (median of
maximum age of RBCs: 23 days) and mortality in multi-
variate analyses [43].
We found six studies with mortality as an outcome in
trauma patients. In a retrospective cohort study of 1,813
severe trauma patients (mean Injury Severity Score (ISS)
26), transfusion of large (but not small) volumes of
older blood (more than 14 days old) was associated with
an increased risk of death compared to transfusion of
the same volumes of younger blood (< 14 days old), sug-
gesting that the age of transfused RBCs could potentiate
the already known association between volume of blood
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Table 2 Overview of the studies reporting the age of transfused red blood cells (RBCs) and patient outcomes.










Summary of main results
Studies addressing mortality
Purdy et al. [42] 1997 1992 Retrospective
single-center
Canada NR ICU septic 31 Non-survivors received a greater
proportion of older RBCs
Mynster et al. [53] 2001 1991-1993 Retrospective
multicenter
Europe No Cancer 740 Mortality not different between
patients transfused with RBCs aged
more or less than 21 days




Trauma 275 No correlation between ‘dose of aged







2,732 No correlation between storage time
variables and 30-day mortality




6,002 Higher hospital and one-year mortality
rate in older blood group












Europe Yes ICU 534 No association between the age of





USA Yes Trauma 1,813 Transfusion of large (but not small)
volumes of older blood associated





USA Yes Trauma 430 Slightly increased mortality with
transfusion of older blood (> 14 days
old)
Spinella et al. [47] 2009 2004-2007 Retrospective
single-center
USA Mix Trauma 202 Hospital mortality higher for patients
transfused with older RBCs; increased
storage time independently associated
with mortality
Edgren et al. [30] 2010 1995-2002 Retrospective
multicenter






USA Yes Trauma 1,647 Trend toward higher mortality rate
with older blood when transfused







4,933 Greater risk of hospital mortality in the





Canada NR PCI 909 Storage duration associated with 30-
day mortality






3,597 No effect of RBC storage duration on







1,153 No association between RBC storage
duration and postoperative mortality
Kekre et al. [54] 2011 2002-2007 Retrospective
single-center
Canada Yes HSCT 555 Non-relapse 100-day mortality
reduced in the subgroup of patients
receiving exclusively old blood (> 14
days old)





Mix ICU 757 Exposure to the highest age quartile
of RBCs associated with a higher
hospital mortality rate compared to
lowest quartile
Hassan et al. [49] 2011 2003-2005 Retrospective
single-center
USA NR Trauma 820 Number of older units not associated
with increased mortality




6,994 No relationship between median RBC
storage duration and postoperative
mortality (up to two years)




509 Transfusion of older blood not
associated with increased two-year
mortality
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Table 2 Overview of the studies reporting the age of transfused red blood cells (RBCs) and patient outcomes.
(Continued)
Kor et al. [28] 2012 2008-2010 Randomized
single-center
study
USA Yes ICU 100 Similar mortality between fresh and
standard issue RBCs but not powered
for this outcome










268 No association between RBC storage
duration and postoperative ICU and
hospital LOS
Keller et al. [58] 2002 1998-1999 Retrospective
single-center
USA No Trauma 86 Number of units of blood older than








585 No association between mean
duration of RBC storage and ICU LOS




Trauma 275 Association between ‘dose of aged







2,732 No correlation between storage time
variables and ICU LOS






670 No association between length of







1,153 No association between length of
storage and ICU LOS




444 Age of blood was a significant but
modest predictor of postoperative
LOS
Kekre et al. [54] 2011 2002-2007 Retrospective
single-center
Canada Yes HSCT 555 No correlation between age of
transfused RBCs and hospital LOS
Studies addressing age of transfused RBCs and occurrence of infections
Edna et al. [61] 1998 1980-1992 Retrospective
single-center
Europe No Cancer 240 Age of RBCs not different in subjects
developing postoperative infections







256 Independent relationship between the
age of transfused RBCs and the
incidence of postoperative pneumonia
or wound infection
Mynster et al. [53] 2001 1991-1993 Retrospective
multicenter
Europe No Cancer 740 Increased risks of postoperative
infections with transfusions of RBCs
aged 20 days or more
Offner et al. [64] 2002 1992- Retrospective
single-center
USA No Trauma 61 Number of units older than 14 and 21








585 Independent relation between the
oldest RBC unit and postoperative
pneumonia
Taylor et al. [66] 2006 2001-2003 Prospective USA Mix ICU 449 Maximum age of transfused RBCs not
associated with increased risks of
nosocomial infections




6,002 Higher rates of postoperative sepsis or
septicemia (but not pneumonia or





USA Yes Trauma 430 Occurrence of pneumonia related to
the volume of old blood (> 14 days
old) transfused






670 No association between storage of





Europe Yes ICU 534 No independent association between
the age of RBCs and nosocomial
infections
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USA Yes Trauma 1,183 Increased risks of pneumonia after
transfusion of exclusively old RBCs (>
14 days)




335 No independent association between








1,153 No association between storage of







1,748 Greater risk of postoperative wound
infections and septicemia with RBCs
older than 14 days
Hassan et al. [49] 2011 2003-2005 Retrospective
single-center
USA NR Trauma 820 Number of units older than 14 days as
a significant risk factor for severe





Europe Yes ICU septic 67 Storage time as a confounder for the





Europe Yes Trauma/TBI 196 Modest association between
transfusion of RBCs older than 14 days
and occurrence of new infections




509 No independent association between
the age of RBCs and postoperative
infections
Studies addressing organ failure
Zallen et al. [68] 1999 NR Retrospective
single-center
USA NR Trauma 63 Mean age of blood (or number of
units older than 14 or 21 days) as










268 Length of RBC storage not associated
with prolonged endotracheal
intubation
Keller et al. [58] 2002 1998-1999 Retrospective
single-center








585 No relationship between RBC storage
duration and prolonged MV
Gajic et al. [70] 2004 2001 Retrospective
single-center
USA Mix ICU 181 No association between mean age or
age of the oldest unit transfused and
occurrence of ALI






670 No association between storage
duration and occurrence of
postoperative renal failure or
prolonged MV




6,002 Increased risk of a composite outcome
(including MOF and renal failure) with
transfusion of older blood; higher
rates of MV > 72 hours when patients





USA Yes Trauma 430 Old blood (> 14 days) associated with








1,153 No association between storage
duration and occurrence of
postoperative renal failure or
prolonged MV




444 Higher rates of renal failure among
patients transfused with old blood
Kor et al. [28] 2012 2008-2010 Randomized
single-center
study
USA Yes ICU 100 Similar measures of pulmonary
function after transfusion of either
fresh or standard issue RBCs
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USA Mix Volunteers 35 Equivalent mild decrements in
pulmonary gas exchange variables
after transfusion of either fresh (1.7
hour) or older (> 21 days) RBCs
Studies addressing tissue oxygenation and microcirculation
Marik et al. [71] 1993 NR Prospective
single-center
study
USA NR ICU 23 Inverse correlation between the age
of transfused RBCs and the maximal








NR ICU septic 15 No correlation between the age of
transfused RBCs and the pHi
Walsh et al. [73] 2004 1999-2000 Randomized
single-center
study
Europe Yes ICU 22 No difference in pHi or gastric to
arterial PCO2 gap with transfusions of
fresh or older RBCs
Sakr et al. [75] 2007 NR Prospective
single-center
Europe Yes ICU 35 No correlation between the storage






Europe Yes Severe TBI 66 Transfusion of RBCs aged more than
19 days failed to increase cerebral
tissue oxygenation
Kiraly et al. [79] 2009 NR Prospective
single-center
USA NR Trauma 32 Patients transfused with > 21 days old
RBCs had a significant decrease in the
area under the curve of tissue
saturation (StO2)
Creteur et al. [81] 2009 NR Prospective
single-center
Europe Yes ICU 44 No association between RBC storage
time and oxygenation variables (NIRS)





20 Increase in perfused vessel density
similar in both RBC age groups





9 Reactive hyperemia index unchanged
after transfusion of 40-day stored








8 No effect of storage duration on tissue






Europe Mix ICU septic 37 No relationship between age of RBCs
and change in lactate/pyruvate ratio
(microdialysis)
Other outcomes





237 No differences in postoperative
bleeding, coagulation tests, or
transfusion requirements
Mynster et al. [53] 2001 1991-1993 Retrospective
multicenter
Europe No Cancer 740 Higher recurrence rate of cancer in
patients who received a transfusion of







585 No association between duration of







USA No Volunteers 9 Reversal of anemia-induced cognitive
dysfunction similar after transfusion of
fresh or stored RBCs
Spinella et al. [47] 2009 2004-2007 Retrospective
single-center
USA Mix Trauma 202 Association between maximum age of
RBCs (> 21 or 28 days) and deep vein
thrombosis (DVT)
Naidech et al. [86] 2011 NR Retrospective
single-center
USA NR SAH 119 No association between age of RBCs
and vasospasm or cerebral infarction
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Table 2 Overview of the studies reporting the age of transfused red blood cells (RBCs) and patient outcomes.
(Continued)
Katsios et al. [85] 2011 2001-2002 Prospective
single-center
Canada No ICU 261 No association between the age of
transfused RBCs and the occurrence of
DVT




316 No association between the age of
transfused RBCs and the five-year
prostate cancer recurrence
DVT, deep vein thrombosis; HSCT, hematopoietic stem cell transplantation; ICU, intensive care unit; LOS, length of stay; LR, leukoreduced; MV, mechanical
ventilation; NIRS, near-infrared spectroscopy; NR, not reported; PCI, percutaneous coronary intervention; SAH, subarachnoid hemorrhage: TBI, traumatic brain
injury.
Table 3 Randomized controlled trials assessing the effects of red blood cell (RBC) storage duration on various









































































the age of transfused
















pHi or gastric to
arterial PCO2
gap
No difference in pHi or
gastric to arterial PCO2


























































vessel density similar in
both RBC age groups
Weiskopf
et al. [69]













































fresh or standard issue
RBCs
ICU, intensive care unit; LR, leukoreduced; MV, mechanical ventilation; NR, not reported.
Lelubre and Vincent Critical Care 2013, 17:R66
http://ccforum.com/content/17/2/R66
Page 9 of 18
transfused and mortality, even though the authors used
universal leukoreduction [44]. The same authors
reported similar data in another retrospective study with
a somewhat higher mortality rate with older blood when
patients received more than three RBC units (20.1% in
fresh blood vs. 27.0% in the old blood group, P = 0.08)
[45]. In less severely injured trauma patients (mean ISS
14.4), transfusion of older blood (> 14 days old) was
also associated with increased mortality, although to a
lesser extent (OR: 1.12, CI: 1.02 to 1.23) [46]. In a smal-
ler retrospective analysis of 202 patients transfused with
at least five units of RBCs, Spinella et al. [47] found that
hospital mortality was higher for patients transfused
with older RBCs (maximum RBC age: 28 or more days)
than with younger RBCs (maximum RBC age less than
28 days) (26.7% vs. 13.9%, P = 0.02). In a multivariate
analysis, increased storage time was independently asso-
ciated with mortality (OR: 4.00; 95% CI: 1.31 to 11.61).
Not all studies in trauma patients have reported deleter-
ious effects of RBC storage on mortality. In a retrospec-
tive study of 271 trauma patients, Murrell et al. [48]
found no correlation between the age of blood (expressed
as the ‘dose of aged blood’) and hospital mortality (OR:
1.21, 95% CI: 0.87 to 1.69) after controlling for confoun-
ders. In another retrospective cohort of 820 transfused
trauma patients, the total number of RBC units but not
the number of older (> 14 days old) units transfused was
independently associated with increased mortality [49].
These studies were, however, smaller than the previous
ones.
Two studies examined the outcomes of medical patients
with cardiovascular disease. In a retrospective study of
4,933 patients, Eikelboom et al. [50] showed a greater risk
of hospital mortality (relative risk 1.48, 95% CI: 1.07 to
2.05) in the highest age quartile of RBCs (31 to 42 days).
In a retrospective cohort study of 909 transfused patients
following percutaneous coronary intervention, RBC sto-
rage duration was associated with 30-day mortality (HR:
1.02 (1.01 to 1.04), P = 0.02). Patients receiving only RBCs
aged > 28 days had an even higher risk of mortality (HR:
2.49 (1.45 to 4.25), P = 0.001) [51]. In a retrospective ana-
lysis of 509 patients undergoing liver transplantation,
transfusion of more than 10 units of RBCs was associated
with increased two-year mortality, but the age of the trans-
fused RBCs was not [52]. In a secondary analysis of a pro-
spective multicenter study on patients with colorectal
cancer [53], transfused patients had a shorter survival than
the non-transfused patients (3.0 years vs. 4.6 years, P =
0.004) but mortality was not significantly different between
patients transfused with RBCs aged more or less than 21
days. In a retrospective single-center study on 555 patients
undergoing hematopoietic stem cell transplantation, non-
relapse 100-day mortality was reduced in the subgroup of
patients receiving exclusively old blood (> 14 days old)
compared to those receiving fresher (< 14 days old) blood
(6% vs. 0% at 100 days, P = 0.04) [54].
Influence on hospital or ICU length of stay
Nine studies evaluated the LOS as a surrogate marker of
global morbidity associated with RBC transfusion. Six of
the studies included cardiac surgery patients; when con-
trolling for potential confounders, there was no relation-
ship between age of transfused RBCs and postoperative
LOS in five of the studies [38,39,41,55,56]. In the only
prospective study, there was a significant association
between ICU LOS and number of units transfused but
not the mean duration of RBC storage [55]. Other retro-
spective studies yielded similar results. In the study of
van De Watering et al. mentioned earlier [38], storage
time had no independent effect on ICU LOS. In the stu-
dies by Yap et al. [41] and McKenny et al. [39], there was
no association between length of storage and ICU LOS.
In another retrospective study of 268 patients undergoing
CABG, Vamvakas and Carven could not find any associa-
tion between RBC storage duration and postoperative
ICU and hospital LOS in a multivariate analyses also con-
trolling for number of units received [56]. One retrospec-
tive study of 444 cardiac surgery patients by Sanders
et al. [57] yielded different results, with the age of blood
a significant but modest predictor of postoperative LOS
(OR: 1.05, 95% CI: 1.01 to 1.09). However, this analysis
was limited by a number of imbalances between groups.
Two studies evaluated LOS in trauma patients. In a
small retrospective study of 86 transfused patients, the
number of units of blood older than 14 days was strongly
associated with an increased hospital LOS [58], each addi-
tional unit older than 14 days old being associated with an
increased length of stay of two days. In the study by Mur-
rell and coworkers mentioned earlier, the dose of aged
blood was significantly associated with a longer ICU stay
(RR 1.15, 95% CI: 1.11 to 1.20) after controlling for con-
founders [48].
In the study by Kekre and coworkers on patients
undergoing hematopoietic stem cell transplantation [54],
there was no correlation between age of transfused
RBCs and hospital LOS.
Influence on infections
Eighteen studies reported on the possible influence of
age of transfused RBCs on the risk of infection.
Studies performed in cardiac surgery patients generated
conflicting results. In the prospective study of Leal-Noval
and coworkers [55], there was an independent relation
between the oldest RBC unit transfused (but not the
mean duration of storage of all the transfused units) and
the development of postoperative pneumonia (OR: 1.06,
95% CI: 1.01 to 1.11, P = 0.018), but not mediastinitis. In
the retrospective study by Koch and coworkers [32],
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patients transfused with older RBCs (> 14 days old) had
significantly higher rates of postoperative sepsis or septi-
cemia (4.0% vs. 2.8%, P = 0.01), whereas rates of pneumo-
nia and wound infections were similar. Two other studies
reported detrimental effects associated with storage time
of non-leukoreduced RBCs. In a retrospective, single cen-
ter study of 256 cardiac surgery patients, Vamvakas et al.
[59] reported an independent relationship between the
age of transfused RBCs and the incidence of postopera-
tive pneumonia or wound infection after correcting for
the number of units transfused. In this study, the risk of
pneumonia increased by 1% per day of increase in the
mean storage time of transfused red cells (P < 0.05). In a
multicenter retrospective Danish study on 1,748 patients
transfused after CABG, storage time more than 14 days
was associated with a greater risk of postoperative wound
infections and septicemia (adjusted OR: 2.5, 95% CI: 1.2
to 4.2). The adjusted risk of severe infection increased by
23% for each unit transfused in patients receiving only
old RBCs [60]. Other studies found no link between sto-
rage time of transfused RBCs and infections. In the smal-
ler cohort of Yap and coworkers [41], no association was
found between storage of RBCs and postoperative pneu-
monia in multivariate analyses. Similar findings were
reported in the study by McKenny and coworkers [39].
Two studies were conducted in patients undergoing
surgery for colorectal cancer. In a single-center, retro-
spective study performed between 1980 and 1992 on
290 patients undergoing colorectal resection for adeno-
carcinoma, age of transfused RBCs was not different in
subjects developing postoperative infections and those
who did not [61]. In a retrospective analysis of 225
patients undergoing colorectal cancer surgery, Mynster
and Nielsen [62] found that a blood storage time
exceeding 20 days was an independent risk factor for
postoperative infection (wound or intra-abdominal
infection, anastomotic leakage, pneumonia, septicemia;
OR, 2.35; 95% CI, 1.27 to 4.37; P = 0.007).
Five studies were conducted in trauma patients, all
suggesting deleterious consequences of storage duration
on infectious complications. In the study by Weinberg
and coworkers [46] evaluating 1,624 trauma patients,
occurrence of pneumonia was directly related to the
volume of old blood (> 14 days old) transfused (OR
1.10, CI 1.04 to 1.17), but not young blood (< 14 days
old), after multiple adjustments. Also, in a retrospective
cohort of 1,183 transfused trauma patients, receipt of
exclusively old RBCs (> 14 days) significantly increased
the risk of pneumonia (adjusted RR for age, gender, ISS,
mechanism of injury, ventilator days and RBC volume
1.42 (1.01 to 2.02)), whereas the transfusion of exclu-
sively young RBCs (< 14 days) or mixed RBCs did not
[63]. In a smaller study of 61 massively transfused
trauma patients, those who developed major infections
had received more units of RBCs greater than 14 or 21
days old. The number of units older than 14 and 21
days was identified as an independent risk factor for
major infections in a multivariate analysis [64]. In the
previously described study by Hassan and coworkers
[49], the number of older (> 14 days old) units of RBCs
transfused was a significant risk factor for severe sepsis
or septic shock especially when more than seven units
were transfused (OR 1.9, 95% CI: 1.1 to 3.4, P = 0.03).
Recently, in a retrospective study of 196 transfused
trauma patients receiving selective digestive tract decon-
tamination, Juffermans et al. found a modest association
between transfusion of RBCs older than 14 days and
occurrence of new infections in multivariate analysis
(OR 1.04, 95% CI 1.01 to 1.07) [65].
We identified three studies in septic and/or ICU
patients. In a prospective study of 449 medical and sur-
gical ICU patients, Taylor and colleagues [66] found
that the number of units of transfused RBCs was asso-
ciated with an increased risk of nosocomial infection in
a multivariate regression analysis, but the maximum age
of transfused RBCs was not. In a retrospective study of
134 patients with sepsis, Juffermans et al. [67] found a
direct relation between the total number of transfused
RBCs and the risk of developing secondary infections
(OR 1.26, 95% CI 1.09 to 1.45) after controlling for
immunosuppression. Storage time was identified as a
confounder for the association of RBCs with infection.
In another retrospective, single-center study of 534 gen-
eral ICU patients, Dessertaine et al. [43] found no inde-
pendent association between the age of transfused red
cells (median of the maximum RBC ages: 23 days) and
the development of nosocomial infection.
The risk of infection was also studied in other popula-
tions. In a retrospective analysis of 509 patients under-
going liver transplantation, Dunn et al. [52] reported no
independent association between the age of transfused
RBCs and the incidence of postoperative infections. In a
secondary analysis of an RCT on patients undergoing
knee arthroplasty, there was no independent association
between postoperative wound infection and age of trans-
fused RBCs [68].
Influence on organ failure (including acute kidney injury
and respiratory failure)
We identified 12 studies that addressed the effects of
transfused RBCs on multiple organ failure (MOF).
Four studies looked at postoperative acute renal failure
in cardiac surgery patients. A retrospective study by
Koch and coworkers [32] found an increased risk of
MOF (unadjusted comparison 0.7% vs. 0.2%, P = 0.007)
and renal insufficiency (unadjusted comparison 2.7% vs.
1.6%, P = 0.003) associated with transfusion of older
blood (> 14 days old). In a multivariate analysis, there
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was an increased risk of a composite outcome (including
MOF and renal failure) associated with transfusion of
older blood (adjusted OR: 1.16; 95% CI: 1.01 to 1.33,
P = 0.03). A smaller study by Sanders and coworkers
[57] also showed somewhat higher rates of renal failure
among patients transfused with any old blood (12.5% vs.
3.1%, P = 0.054) (unadjusted risks) compared to other
patients. In a multivariate analysis, every day increase in
storage was associated with a 7% increase in risk of new
renal complications. These results have been challenged
by two other studies that found no association between
storage duration and occurrence of postoperative renal
failure [39,41].
Two studies included trauma patients. In a small study
of 63 matched case-control trauma patients, Zallen and
coworkers found that mean age of blood and number of
units older than 14 or 21 days were independent risk
factors for MOF in a limited multivariate analysis [68].
In a study by Weinberg et al. [45] the receipt of old
blood (> 14 days old) was associated with acute renal
dysfunction (OR 1.18, CI 1.07 to 1.29) after adjustment
for age, sex, ISS, thoracic injury and need for mechani-
cal ventilation, whereas the receipt of young blood (< 14
days old) was not.
Some studies focused on the development of respira-
tory failure, assessed by physiologic and immunologic
variables, or the duration of mechanical ventilation
(MV). In a randomized, crossover study of 35 healthy
volunteers, Weiskopf and coworkers [69] found equiva-
lent mild decrements in pulmonary gas exchange
(alveolo-arterial oxygen gradient ((A-a)DO2), dead space
to tidal volume ratio (VD/VT)) after isovolemic transfu-
sion of either two units of fresh (1.7 hour) or older (>
21 days) autologous RBCs. No differences between leu-
koreduced and non-leukoreduced units were noted.
Also, in a single-center randomized clinical trial in
mechanically ventilated ICU patients, patients rando-
mized to receive exclusively fresh RBCs (n = 50 patients,
median RBC age: 4.0 days) had similar measures of pul-
monary function (changes in PaO2/FIO2 ratio, changes
in VD/VT, static compliance) when compared to those
receiving standard issue RBCs (n = 50 patients, median
RBC age: 26.5 days) [28]. Eight other observational stu-
dies analyzed the duration of MV or the occurrence of
ALI. In the study by Koch and coworkers [32] in 6,002
cardiac surgery patients, patients receiving only old
RBCs (14 days) had higher rates of MV > 72 hours com-
pared to those transfused with only younger (< 14 days)
blood (unadjusted risk 9.7% vs. 5.6%, P < 0.001) but no
adjusted risk for longer MV duration was calculated.
These findings were not found in six other studies
[39,41,46,55,56,58]. In a retrospective study on 181
mechanically ventilated ICU patients, Gajic and cowor-
kers [70] found no association between storage variables
(mean age or age of the oldest unit transfused) and
occurrence of ALI.
Influence on tissue oxygenation and the microcirculation
Several studies using various devices addressed the ques-
tion of whether aged RBCs could alter the microcircula-
tion in humans. In a prospective, non-randomized study
of 23 septic patients, Marik and Sibbald [71] reported
an inverse correlation between the age of transfused
RBCs (three units of stored RBCs of varying age) and
the maximal change in gastric mucosal pH (pHi) during
the subsequent hours (r = -0.71, P < 0.001). In a multi-
variate analysis, age of transfused RBCs was the only
predictor of the changes in pHi, suggesting that older,
less deformable RBCs could promote mucosal ischemia.
These data were, however, challenged by later studies.
In particular, Fernandes and colleagues [72] compared
15 anemic septic patients randomly assigned to receive
either one RBC unit (mean storage time: 12.8 ± 8.1
days) or 500 mL of a 5% albumin solution. There was
no increase in oxygen delivery or consumption following
RBC transfusion (but the baseline hemoglobin concen-
tration was relatively high) and no correlation between
the age of transfused RBCs and the pHi. Likewise, in a
randomized, double-blinded study on 22 anemic ICU
patients, Walsh and coworkers [73] reported no differ-
ence in pHi or gastric to arterial PCO2 gap with transfu-
sions of two units of leukoreduced RBCs stored for less
than five days (median: 2 days) or more than 20 days
(median: 28 days). Comparisons of this work with the
previous study by Marik and Sibbald [71] is difficult
because of differences in patient populations and the
use or not of leukodepleted blood [74]. Sakr and cowor-
kers [75] performed a prospective study evaluating
transfusion-induced changes in the sublingual microcir-
culation of 35 septic patients (using an orthogonal
polarization spectral imaging technique). Oxygen uptake
and microcirculatory variables were globally unaltered
after the administration of one or two units of leukore-
duced RBCs (median age: 24 days; IQR: 12 to 28 days);
considerable interindividual variability in sublingual
capillary perfusion was noted among these patients and
no correlation between the storage time and the changes
in capillary perfusion was found [75].
In another small randomized trial on 20 hematology
outpatients transfused with three units of either young
(median: 7 days) or older blood (median: 23 days), viscos-
ity and perfused vessel density in sublingual microcircula-
tion (assessed with sidestream dark field imaging - SDF)
increased after transfusion, but this increase was similar in
both RBC age groups [76]. Interestingly, the aggregability
index was also increased following RBC transfusion
whereas the RBC deformability index was unchanged, with
no differences between older and younger blood groups.
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Leal-Noval and coworkers [77] assessed the effects of
transfusion of leukoreduced RBCs on cerebral tissue oxy-
genation (PtiO2) in patients with severe traumatic brain
injury divided into four quartiles according to length of
storage of transfused RBCs (< 10 days, n = 18; 10 to 14
days, n = 15; 15 to 19 days, n = 17; > 19 days, n = 16).
Transfusion of RBCs stored for less than 19 days increased
PtiO2 for up to six hours, whereas transfusion of RBCs
aged more than 19 days failed to do so. There was a trend
toward an inverse relationship between storage time and
the relative increment in PtiO2 from the baseline value,
but there were concerns about methodological limitations
in this study [78]. Kiraly and coworkers [79] performed a
prospective, non-randomized study in 32 hemodynami-
cally stable, non-septic, ICU trauma patients requiring a
transfusion. Patients transfused with ‘old’ red cells (> 21
days old, n = 17 patients) had a significant decrease in the
area under the curve (AUC) of tissue oxygen saturation
(StO2) as measured by near-infrared spectroscopy (NIRS
[80]), whereas patients receiving ‘new’ red cells (< 21 days,
n = 15 patients) and a control, non-transfused group had a
stable StO2 AUC. Moreover, a slightly negative correlation
between the age of the oldest unit transfused and the
changes in oxygenation was noted (r2 = 0.25). In a pro-
spective study on 44 hemodynamically stable ICU patients
also monitored with NIRS, Creteur and coworkers [81]
found no association between RBC storage time (median:
18 days; IQR: 11 to 27 days) and oxygenation variables
(changes in the StO2 upslope, changes in NIR oxygen con-
sumption). Also, in a randomized crossover study in nine
healthy volunteers, reactive hyperemia index (measured by
peripheral arterial tonometry and reflecting NO bioavail-
ability and endothelial function) was unchanged after
transfusion of one unit of 40-day stored autologous blood
compared with transfusion of three-day stored blood [82].
Another recent study on eight healthy volunteers receiving
sequentially one unit of seven-day AS-3 stored and one
unit of 42-day stored autologous blood found no effect of
storage duration on oxygenation variables (tissue oxygen
saturation - brain and thenar eminence, and sublingual
microcirculatory flow index) [83]. Recently, Kopterides
et al. [84] reported no relationship between age of trans-
fused RBCs (median: 16 days) and post-transfusional
change in lactate/pyruvate ratio (microdialysis assessment)
in 37 ICU patients with sepsis.
Other outcomes
a) Thrombotic events
In a retrospective study of 202 trauma patients, Spinella
and coworkers found an association between maximum
age of transfused RBCs (> 21 or 28 days) and the occur-
rence of deep vein thrombosis (DVT) but no multivariate
analysis was performed to confirm this observation [47].
Moreover, these results were challenged by a prospective
study of 261 medico-surgical ICU patients in which there
was no association between the age of transfused RBCs
and the occurrence of DVT [85]. Leal-Noval and cowor-
kers found no association between duration of storage of
transfused RBCs and postoperative myocardial infarction
[55].
b) Vasospasm after subarachnoid hemorrhage
In a retrospective, single-center study of 119 patients
transfused after SAH, Naidech and coworkers could not
find any association between age of RBCs and poor out-
comes (vasospasm, cerebral infarction, dependence or
mortality at three months) [86].
c) Bleeding
One may hypothesize that stored blood (especially in
the absence of leukoreduction) could increase bleeding
through an altered viability of platelets and a decrease
in coagulation factors, such as factor VIII. In patients
undergoing CABG surgery, Wasser and coworkers [87]
found no differences in postoperative bleeding, coagula-
tion tests, or transfusion requirements between the
study group (two units of fresh blood followed by stored
RBCs (aged from two to five days) if required) and the
control group (stored blood only), except for a subgroup
of patients with thrombocytopenia.
d) Cognitive dysfunction
In a randomized crossover study on healthy volunteers
submitted to acute normovolemic hemodilution (target
hemoglobin 5 g/dl), Weiskopf et al. [88] found that
reversal of anemia-induced cognitive dysfunction was
similar after transfusion of two units of fresh (storage
less than five hours) or stored (three weeks storage)
RBCs.
e) Cancer recurrence
Immunomodulation associated with RBC transfusion
may influence cancer recurrence after surgery. In a ret-
rospective study of 740 patients with colorectal cancer,
Mynster and coworkers [53] found a higher recurrence
rate of cancer in patients who received a transfusion of
RBCs stored < 21 days (HR: 1.5; 95% CI: 1.04 to 2.18,
P = 0.03 for colorectal cancer) than in patients who
received blood stored ≥ 21 days. Another retrospective
study of 316 patients undergoing surgery for prostate
cancer found no association between the age of trans-
fused allogeneic RBCs and the five-year cancer recur-
rence defined by prostate specific antigen levels [89].
Discussion
It is interesting to note the quasi-exponential growth in
the number of publications related to the impact of
RBC storage since 1989, with 50% of the studies pub-
lished during or after 2009. We identified 55 studies
that reported an association between RBC storage and
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outcomes in adult patients. Of these, 26 studies (47%)
suggested detrimental effects of RBC storage on any
clinical endpoint, whereas the remainder (53%) did not.
Comparison among studies is difficult because of the
high degree of heterogeneity. First, studies included differ-
ent patient populations (cardiac surgery, trauma, sepsis,
cancer patients) with different baseline risks. Interestingly,
91% of the studies on trauma patients showed a deleter-
ious impact of older RBCs on any endpoint, whereas only
45% of studies in cardiac surgery patients and 36% of stu-
dies in ICU patients suggested such an association. It is
intriguing to consider that trauma patients may be more
sensitive to the age of transfused RBCs than other patients
[90]. Second, studies also included different mortality and
morbidity outcomes and the criteria for organ dysfunction
varied. Third, the way in which the age of transfused RBCs
was reported also varied (mean age of all RBCs transfused,
maximum age of RBCs, mean of the two oldest units, pro-
portion of RBCs older than a given number of days,...),
each analysis having its own advantages and limitations.
Studies that report the mean or median age of all units
transfused assume that fresher units offset the deleterious
effect of older blood but this may not be true. Dichotomi-
zation of RBC age below or above a given time based on
more or less proven pathophysiological evidence may also
be problematic [18,91]. Recently, in a simulation-based
analysis of four RCTs (three currently ongoing) that used
distinct categorization of RBC storage, the type of tem-
poral pattern assumed for the RBC storage lesion (smooth
or sharp sigmoid curve centered on 7, 21 or 35 days; linear
relation) had a profound impact on the statistical power of
the trials for various outcomes, such that it was below 80%
in numerous cases [91]; in particular, none of the studies
had sufficient power to detect harmful consequences of
RBC storage lesions if they were assumed to occur during
the last week of storage. One must take into account the
fact that older units are more often transfused during mas-
sive transfusions, which are obviously associated with
worse outcomes [18]. Fourth, the blood preparation,
including leukoreduction and use of additive solutions,
varied among the studies; these practices have evolved
over time and place and may influence the results. We
found only 17 studies (35% of all studies) that reported
use of exclusively leukoreduced RBCs, 10 studies (20%)
reporting use of exclusively non-leukoreduced units and
11 studies (22%) reported use of a mix of leukoreduced
and non-leukoreduced RBCs.
Most of the studies were retrospective with associated
limitations. Control for potential confounders is particu-
larly important. Problems with bias (recently reviewed
and listed in [18]) are well illustrated by the phenom-
enon of confounding by indication, occurring when the
indication for a treatment causes the outcome studied
[92]. The most notable example of this effect concerns
sicker patients who have a poorer prognosis and are
also prone to receive more blood transfusions, leading,
if no correction is applied, to the spurious association
between number of blood transfusions and poorer out-
comes. Another, more subtle problem is that patients
who need multiple transfusions are, in general, more
likely to receive some older blood [38,92]. Transfusion
thresholds, which have evolved over time and may vary
between centers, may also play a role because they may
modify the global exposure of a patient population to
blood transfusions. Also, temporality of the association
between transfusion and outcome is not always clear.
Statistical methods, like multivariate analyses, are
required to correct for some biases (for example, correc-
tion for the total number of units transfused, which is
one of the most important biases in the transfusion lit-
erature). In some studies, there was poor control for the
number of transfused RBCs or imbalances in ABO
groups [32,93] and possibly other unknown biases. The
small number of patients included in many studies may
also be of concern: ‘negativity’ of small studies should
not be interpreted as proof for absence of effect [18].
Unfortunately, performing a quantitative meta-analysis
is complicated by the significant clinical heterogeneity
between studies, even if tests for statistical heterogeneity
are passed. Moreover, meta-analyses do not improve the
quality of individual studies [94], a major concern in our
systematic review, which identified numerous biased stu-
dies. For these reasons we chose not to perform a meta-
analysis. Nevertheless, some have been attempted [20-22],
resulting, not surprisingly, in conflicting results. The most
recent meta-analysis by Wang and coworkers showed det-
rimental effects of RBC storage on mortality (pooled OR
1.16; 95% CI 1.07 to 1.24, P = 0.0001), pneumonia (pooled
OR 1.17; 95% CI 1.08 to 1.27, P = 0.0001) and multiple
organ dysfunction syndrome (pooled OR 2.26; 95% CI
1.56 to 3.25, P < 0.0001); in this study, 97 patients (95% CI
63 to 199) was cited as the number to treat with exclu-
sively fresh blood to save one life [20]. Another meta-
analysis by Vamvakas that included only studies reporting
adjusted results for mortality, found that the age of blood
was not associated with a higher risk of mortality [22].
Transfusion policies in some centers recommend use
of fresh RBCs for special populations, such as fetuses
(intrauterine transfusions) or neonates, although the evi-
dence for this approach is poor [95]. If one could choose,
one would prefer fresher blood, although storage for a
few days at 4°C may be beneficial to reduce the risk of
some cell-associated viruses and other pathogens that
cannot survive for long in these conditions [95]. More-
over, the delivery of fresher blood may be associated with
major organizational problems although some recent
pilot trials suggest the feasibility of such an approach
[96,97]. Some would argue that the best way to resolve
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this problematic issue with adequate control for known
and unknown biases may be achieved by large RCTs. It is
intriguing to note that among eight randomized trials
already published (without pilot trials) [28,69,72,73,
76,82,87,88], none demonstrated detrimental effects of
RBC storage duration on outcomes, although the studies
were small and mostly reported physiological outcomes.
Several large randomized studies are ongoing (notably
ABLE [98] and RECESS [99]) and their investigators have
had to face various obstacles. First, as the differences in
clinically relevant outcomes (such as mortality) are (if
present) expected to be low, large numbers of patients
are required to detect these differences. Second, these
trials must overcome logistic problems so that the blood
banks can appropriately deliver exclusively young or
older RBC units (compared to an a priori defined thresh-
old), as illustrated in several studies [96,100-102]. Third,
even if the duration of storage is still within acceptable
limits, administration of exclusively older RBCs to
patients may raise ethical concerns. Use of standard
RBCs instead of exclusively old RBCs may overcome this
issue (for example, in the ABLE study [98]).
Our study has several strengths and limitations. First,
we considered clinically relevant outcomes, which we dis-
cussed separately and were the basis for the study classifi-
cation. Studies reporting biological outcomes (hemolysis
[103], survival of RBCs after transfusion [104], hematocrit
response [105] or mitogenic activity of plasma after
transfusion [106]), or evolution of clinical scores after
RBC administration [107], were not considered. Pediatric
studies were also not included, because newborns and
children may represent a particular population with spe-
cific pathologies. Also, we did not consider feasibility stu-
dies (pilot trials before large RCTs) [96,97,101], which
were not primarily powered to assess the clinical rele-
vancy of RBC storage duration. Finally, we chose to
refrain from performing a quantitative meta-analysis
because of the high number of biased studies, which
could have led to erroneous conclusions.
In conclusion, our systematic review indicates that the
influence of RBC age on various outcomes is equivocal.
The quality of the evidence is currently too poor to
make recommendations to change current transfusion
practice. Our observations are reassuring, because major
differences would have serious consequences for the
organization of blood banks [108].
Key messages
• The duration of red blood cell (RBC) storage
before transfusion may alter RBC function and,
hence, potentially influence the incidence of compli-
cations or even mortality, but this is controversial.
• Fifty-five studies were identified that had reported
the effects of age of transfused RBCs on mortality or
morbidity in adult patients, but the marked hetero-
geneity among studies prevented a formal meta-
analysis.
• Half of the studies showed no deleterious effects of
aged compared to fresh blood on any endpoint.
• This systematic review found no definitive argu-
ment to support the superiority of fresh over older
RBCs for transfusion.
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